Open AccessA Durable Response to Relapsing Clostridium difficile Colitis May Require Combined Therapy with High-dose Oral Vancomycin and Intravenous Immune Globulin
Author(s) -
Lawrence A. Cone,
Carlos López,
Harold L. Tarleton,
V. Douglas Jodoin,
Murray Taylor,
Radikha Gade-Andavolu,
Luke Dreisbach
Publication year - 2006
Publication title -
infectious diseases in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.145
H-Index - 21
eISSN - 1536-9943
pISSN - 1056-9103
DOI - 10.1097/01.idc.0000222619.48650.d2
Subject(s) - medicine , clostridium difficile , colitis , pseudomembranous colitis , vancomycin , clostridium difficile toxin a , antibody , gastroenterology , diarrhea , metronidazole , asymptomatic , clostridium difficile colitis , immunology , antibiotics , microbiology and biotechnology , staphylococcus aureus , genetics , bacteria , biology